Provectus Biopharmaceuticals (PVCT) Return on Equity [ROE] (2011 - 2017)
Provectus Biopharmaceuticals' Return on Equity [ROE] came in at -1600.17% for Q1 2017, down 1413.05 percentage points from -187.11% a year earlier and down 1041.79 percentage points from the prior quarter.
Provectus Biopharmaceuticals (PVCT) Return on Equity [ROE] (2011 - 2017) Analysis & Trends
For FY2016, Provectus Biopharmaceuticals' Return on Equity [ROE] was -247.75%, down 128.98 percentage points from FY2015.
- Return on Equity [ROE] carries a five-year change of -40.80 percentage points (FY2011 to FY2016).
- Going back by year, Return on Equity [ROE] was -118.77% in FY2015 (-39.40 pp), -79.37% in FY2014 (+157.00 pp), -236.37% in FY2013 (-37.44 pp) and -198.93% in FY2012 (+8.02 pp).
- The Q1 2017 figure represents the lowest quarterly Return on Equity [ROE] in data going back to Q3 2011.
- Year-over-year, Return on Equity [ROE] has declined for six consecutive quarters, with an average year-over-year change of -316.61 percentage points over the last eight quarters.
- The fastest year-over-year change in Return on Equity [ROE] over five years came in Q3 2013 (a gain of 232.62 percentage points), and the weakest in Q1 2017 (a drop of 1413.05 percentage points).
- Business Quant data shows PVCT's Return on Equity [ROE] at -558.38% (Q4 2016), -401.23% (Q3 2016) and -248.58% (Q2 2016) in the three quarters before Q1 2017.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,149.64 Bn | 1,118.23 Bn | 19.71 Bn | 82.09% |
| 2 | Johnson & Johnson | 626.55 Bn | 545.08 Bn | 17.26 Bn | 25.32% |
| 3 | AbbVie | 498.79 Bn | 471.91 Bn | 12.70 Bn | - |
| 4 | Merck | 371.66 Bn | 326.04 Bn | 12.21 Bn | 7.21% |
| 5 | Novartis Ag | 299.96 Bn | 263.95 Bn | 11.24 Bn | 31.52% |
| 6 | Astrazeneca | 263.22 Bn | 236.91 Bn | 12.86 Bn | 21.39% |
| 7 | Amgen | 237.03 Bn | 192.43 Bn | 7.24 Bn | 83.75% |
| 8 | Gilead Sciences | 191.20 Bn | 165.40 Bn | 6.22 Bn | -18.38% |
| 9 | Pfizer | 170.83 Bn | 117.47 Bn | 10.94 Bn | 4.97% |
| 10 | Provectus Biopharmaceuticals | 21.01 Mn | 19.10 Mn | - | - |
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2017 | -1,600.17% |
| Dec 31, 2016 | -558.38% |
| Sep 30, 2016 | -401.23% |
| Jun 30, 2016 | -248.58% |
| Mar 31, 2016 | -187.11% |
| Dec 31, 2015 | -120.69% |
| Sep 30, 2015 | -55.69% |
| Jun 30, 2015 | -51.20% |
| Mar 31, 2015 | -54.88% |
| Dec 31, 2014 | -56.46% |
| Sep 30, 2014 | -76.96% |
| Jun 30, 2014 | -87.14% |
| Mar 31, 2014 | -133.91% |
| Dec 31, 2013 | -169.71% |
| Sep 30, 2013 | -165.04% |
| Jun 30, 2013 | -209.77% |
| Mar 31, 2013 | -271.63% |
| Dec 31, 2012 | -366.77% |
| Sep 30, 2012 | -397.67% |
| Jun 30, 2012 | -368.37% |
Provectus Biopharmaceuticals Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=PVCT&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "PVCT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=PVCT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();